Related Experiment Video
Updated: Oct 3, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Isolation of a DNA probe for identification of Mycobacterium kansasii, including the genetic subgroup
1Infectious Diseases Department, First Affiliated Hospital, Suzhou Medical College, People's Republic of China.
Abstract:
In order to develop a DNA-based assay to identify all Mycobacterium kansasii clinical isolates, a specific DNA probe was isolated in plasmid p6123. A total of 145 M. kansasii clinical isolates were collected from several countries and were examined with three probes by DNA hybridization. Of the 145 isolates, 115 (79%) were positive with the previously described probe pMK1-9 (Z. H. Huang, B. C. Ross, and B. Dwyer, J. Clin. Microbiol. 29:2125-2129, 1991), 129 (88%) were positive with the commercial Accu-probe assay (Gen-Probe), and 145 (100%) were positive with the p6123 probe. Southern blot analysis of EcoRI-digested M. kansasii chromosomal DNA with p6123 revealed that all Accu-probe-positive M. kansasii strains exhibited a 3-kb fragment, whereas all Accu-probe-negative M. kansasii strains displayed DNA fragments of variable molecular sizes. These results indicate that, unlike the previously described probes for M. kansasii, the fragment cloned into p6123 identified all 145 biochemically typical strains tested and provides an ideal target for future DNA-based speciation assays.
Insights
A novel DNA probe, p6123, successfully identified 100% of Mycobacterium kansasii clinical isolates. This probe offers superior accuracy for developing new DNA-based diagnostic assays for this bacterium.
Area of Science:
- Microbiology
- Molecular Biology
- Medical Diagnostics
Background:
- Mycobacterium kansasii is a significant pathogen requiring accurate identification.
- Existing DNA probes for M. kansasii have limitations in sensitivity and specificity.
- Development of a comprehensive DNA-based assay is crucial for clinical diagnostics.
Purpose of the Study:
- To isolate and characterize a specific DNA probe for identifying all clinical isolates of Mycobacterium kansasii.
- To evaluate the diagnostic performance of the novel probe compared to existing methods.
Main Methods:
- Isolation of a specific DNA probe (p6123) from M. kansasii.
- DNA hybridization assays using the p6123 probe on 145 clinical M. kansasii isolates.
- Comparison with a previously described probe (pMK1-9) and a commercial assay (Accu-probe).
- Southern blot analysis to investigate DNA fragment patterns.
Main Results:
- The p6123 probe achieved 100% identification of all 145 M. kansasii isolates tested.
- Previous probes identified 79% (pMK1-9) and 88% (Accu-probe) of the isolates.
- Southern blot analysis revealed distinct DNA fragment patterns differentiating strains.
Conclusions:
- The p6123 DNA probe is highly specific and sensitive for identifying all tested Mycobacterium kansasii clinical isolates.
- This probe represents an ideal target for developing advanced DNA-based speciation assays.
- The findings enhance the potential for accurate and comprehensive diagnostics of M. kansasii infections.
Related Concept Videos
DNA Isolation
Labeling DNA Probes
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Modern Molecular Taxonomy
Applications of Molecular Taxonomy

